PYC Therapeutics Limited (ASX:PYC) insider Alan Tribe bought 600,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 17th. The stock was purchased at an average cost of A$0.14 ($0.10) per share, for a total transaction of A$81,000.00 ($57,857.14).
The company has a debt-to-equity ratio of 2.64, a current ratio of 36.23 and a quick ratio of 36.15.
About PYC Therapeutics
Featured Story: What are benefits of a growth and income fund?
Receive News & Ratings for PYC Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PYC Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.